Q1 2021 13F Holders as of 31 Mar 2021
-
Type / Class
-
Equity / Class 'A' Ordinary Shares
-
Shares outstanding
-
385,837,333
-
Number of holders
-
31
-
Total 13F shares, excl. options
-
5,404,173
-
Shares change
-
-532,120
-
Total reported value, excl. options
-
$20,322,000
-
Value change
-
-$2,001,163
-
Put/Call ratio
-
88.83%
-
Number of buys
-
12
-
Number of sells
-
-14
-
Price
-
$3.76
Significant Holders of Trinity Biotech plc - Class 'A' Ordinary Shares (TRIB) as of Q1 2021
37 filings reported holding TRIB - Trinity Biotech plc - Class 'A' Ordinary Shares as of Q1 2021.
Trinity Biotech plc - Class 'A' Ordinary Shares (TRIB) has 31 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 5,404,173 shares
of 385,837,333 outstanding shares and own 1.4% of the company stock.
Largest 10 shareholders include RENAISSANCE TECHNOLOGIES LLC (1,844,963 shares), HUNTER ASSOCIATES INVESTMENT MANAGEMENT LLC (1,642,959 shares), ACADIAN ASSET MANAGEMENT LLC (753,293 shares), STONEHILL CAPITAL MANAGEMENT LLC (488,934 shares), MORGAN STANLEY (111,489 shares), MARSHALL WACE, LLP (90,680 shares), Navellier & Associates Inc (81,746 shares), MILLENNIUM MANAGEMENT LLC (59,019 shares), TWO SIGMA INVESTMENTS, LP (39,316 shares), and Squarepoint Ops LLC (36,450 shares).
This table shows the top 31 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.